For cross-border merger and acquisition projects, Mr. Liu has advised clients in many aspects throughout all phases of transactions, including transaction structure design, due diligence exercises, drafting / reviewing transaction documents, negotiations, providing relevant legal opinions and deal closings. Mr. Liu has provided the aforementioned legal services to many Fortune 500 multi-national companies and Chinese companies. Mr. Liu's clients cover a wide range of industries, including without limitation to manufacturing, automobile, aerospace, insurance, energy, pharmaceutical, agriculture, retail, TMT, and consulting. Meanwhile, Mr. Liu also assists Chinese companies in their outbound investment projects and has provided legal services to Chinese companies investing or acquiring targets in North America, Europe, and Asia Pacific regions.
Global Law Office
Global Law Office‘s healthcare and life sciences team aims to provide a “one-stop” service for clients in the sector, handling M&A, investment and funding, licensing, day-to-day operational matters, IP protection, and compliance advice. The firm assists major MNCs in this capacity – including GSK, Roche and Amgen – as well as PRC state-owned enterprises. The practice is led jointly by Alan Zhou, a specialist in private equity and venture capital funds in the life sciences and medical technology field, and M&A and foreign direct investment specialist Michael Yu. Jerry Liu is also integral, with experience acting for investors as well as directly for biopharmaceutical companies. Licensing and collaboration agreements expert Charlene Huang, healthcare compliance specialist Coco Fan and certified fraud examiner Jacky Li are further key cogs in the team, as is associate Stephanie Wang.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The team has strong knowledge of life sciences and biomedicine.’
‘The team has global vision and rich overseas and domestic legal knowledge, as well as practical experience.'
Key clients
- Amgen
- BMS
- Roche
- Johnson & Johnson
- GSK
- Abbive
- Sanofi
- Shanghai Pharma
- Hengrui
- Boehringer Ingelheim Co., Ltd.
- CARsgen Therapeutics Holdings Limited
- Full-Life Technologies
- Jemincare Group Co., Ltd.
- Novagenesis Therapeutix Inc.
- Viva Star Bioscience Inc.
- Morningside Venture
Work highlights
- Assisted Full-Life Technologies with acquiring Focus-X Therapeutics.
- Advised MSD, IDG Capital and several other investors on their participation in the Sichuan Kelun Biotech Series B round of financing.
- Assisted CARsgen Therapeutics in its cooperation with Huadong Medcine on B-cell maturation antigen (BCMA) CAR T therapy, CT-053.
Lawyers
Leading individuals
Next Generation Partners
Ms. Fan is the legal counsel of many multi-national companies in Mainland China, including Sanofi, Boehringer Ingelheim, MSD, GSK, Novartis, Eli Lilly, Catalent, BRITA GmbH, TOSOH SMD Inc., Schlumberger, Shanghai Jiaotong University School of Medicine, Gensci、Bureau Veritas, Biomet, Capital Today, Qiming Venture Partners, DT Capital, HGI FINAVES China Fund, etc. Ms. Fan has rich legal and regulatory compliance experiences in the healthcare industry involving prescription medicine, OTC, CRO, medical device, biopharmaceuticals, health foods, clinical supply, vaccine, animal health and hospitals, etc.
Practice head
The lawyer(s) leading their teams.
Alan Zhou, Michael Yu